
Autoantibodies to domain 1 of beta 2 glycoprotein 1: A promising candidate biomarker for risk management in antiphospholipid syndrome
Keywords: لوپوس اریتماتوی سیستمیک; ACR; American College of Rheumatology; A5R; annexin A5 resistance; aPL; anti-phospholipid; APS; anti-phospholipid syndrome; β2GP1-D1; Beta 2 glycoprotein 1 domain 1; CIA; chemiluminescence assay; CL; cardiolipin; LAC; lupus anticoagulant; LR; likelihood